News
CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced it will deliver Developing Topics (late-breaking) virtual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback